Skip to main content

Krempa David's Form 4 filing

Eton Pharmaceuticals, Inc. (ETON) · filed May 27, 2026

Accession no.
0001437749-26-018628
Filed
May 27, 2026
Trade date
May 22-27, 2026
Filing delay
5 days
Rule 10b5-1 plan
Not checked

This filing lists 10 non-derivative transactions and 5 derivative transactions. Open-market sales total $3.23M. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Krempa DavidCIK 0001968254Officer (Chief Business Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 22, 2026Common StockMOption exerciseAcquired+30,591$3.58+$109,515.7868,046Direct
May 22, 2026Common StockSSaleDisposed−32,963$33.22−$1,095,030.8635,083Direct
May 22, 2026Common StockSSaleDisposed−9,315$33.88−$315,592.225,768Direct
May 22, 2026Common StockSSaleDisposed−519$35.00−$18,16525,249Direct
May 26, 2026Common StockMOption exerciseAcquired+25,000$1.38+$34,50050,249Direct
May 26, 2026Common StockMOption exerciseAcquired+12,524$1.37+$17,157.8862,773Direct
May 26, 2026Common StockSSaleDisposed−37,524$31.49−$1,181,630.7625,249Direct
May 27, 2026Common StockMOption exerciseAcquired+12,476$1.37+$17,092.1237,725Direct
May 27, 2026Common StockMOption exerciseAcquired+7,203$3.58+$25,786.7444,928Direct
May 27, 2026Common StockSSaleDisposed−19,679$31.47−$619,298.1325,249Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 22, 2026Common StockMOption exerciseDisposed−30,591$0.00$0125,609Direct
May 26, 2026Common StockMOption exerciseDisposed−25,000$0.00$00Direct
May 26, 2026Common StockMOption exerciseDisposed−12,524$0.00$012,476Direct
May 27, 2026Common StockMOption exerciseDisposed−12,476$0.00$00Direct
May 27, 2026Common StockMOption exerciseDisposed−7,203$0.00$0118,406Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)